IDH1 and acute myeloid leukemia: Missense mutations in both cytosolic IDH1 and mitochondrial IDH2 are identified frequently in grade II and III astrocytomas and oligodendrogliomas, secondary glioblastomas, and acute myeloid leukaemia (AML)3,4.